Weight Watchers is Novo Nordisk's latest partnersip.

Novo Nordisk A/S (NYSE:NVO) ranks among the best set-it-and-forget-it stocks to buy. Novo Nordisk A/S (NYSE:NVO) announced on ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a ...

The partnership helps Novo capture patients who have been using compounded versions of the medicine, while allowing ...

Novo Nordisk (NVO) partners with WeightWatchers to expand access to Wegovy through NovoCare Pharmacy after ending a deal with Hims & Hers (HIMS). Read more here.

Novo Nordisk is partnering with WeightWatchers to offer consumers access to Wegovy after it abruptly ended its collaboration with Hims & Hers.

Now, Novo Nordisk has identified Weight Watchers to step into that gap, despite filing for bankruptcy in May. The telehealth company joins Ro and LifeMD, who are already collaborating with Novo ...

The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1.

PLAINSBORO, N.J. - Novo Nordisk announced today a new collaboration with WeightWatchers to expand patient access to its FDA-approved weight loss medication Wegovy (semaglutide) beginning July 1 ...